We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.9B
AUM Growth
+$404M
(+1%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
14.11%
Holding
812
New
105
Increased
224
Reduced
322
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$166M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$149M |
| 3 |
AbbVie
ABBV
|
+$148M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$129M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$846M |
| 2 |
Stanley Black & Decker
SWK
|
+$190M |
| 3 |
Citigroup
C
|
+$156M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$151M |
| 5 |
Air Products & Chemicals
APD
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 12.19% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.4% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Compass Minerals
CMP
$1.25B
| $51.4M | 0.13% |
591,900
+234,497
| +66% | +$20.1M |
|
227
Liberty Global Class C
LBTYK
$3.49B
| $51.3M | 0.13% |
1,313,352
| – | – |
|
|
DFS
228
DELISTED
Discover Financial Services
DFS
| $51.3M | 0.13% |
783,608
+227,550
| +41% | +$14.6M |
|
229
Norfolk Southern
NSC
$75B
| $50.9M | 0.12% |
464,206
-6,500
| -1% | -$712K |
|
|
HES
230
DELISTED
Hess
HES
| $50.5M | 0.12% |
684,100
+315,200
| +85% | +$25M |
|
|
FTR
231
DELISTED
Frontier Communications Corp.
FTR
| $50M | 0.12% |
500,113
-1,780
| -0.4% | -$175K |
|
|
MRD
232
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $49.7M | 0.12% |
2,756,573
+1,582,273
| +135% | +$35.4M |
|
|
DRC
233
DELISTED
DRESSER-RAND GROUP INC
DRC
| $49.1M | 0.12% |
600,000
+388,286
| +183% | +$31.6M |
|
|
ACOR
234
DELISTED
Acorda Therapeutics
ACOR
| $49M | 0.12% |
10,000
+1,667
| +20% | +$7.15M |
|
|
HCBK
235
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $48.9M | 0.12% |
4,831,036
-12,800
| -0.3% | -$124K |
|
|
AUXL
236
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $48.9M | 0.12% |
+1,421,600
| New | +$46.4M |
|
237
Eaton
ETN
$150B
| $48.8M | 0.12% |
717,456
-7,313
| -1% | -$482K |
|
238
Incyte
INCY
$24.9B
| $48.6M | 0.12% |
664,790
-435,210
| -40% | -$28.4M |
|
239
CMS Energy
CMS
$22.7B
| $48.3M | 0.12% |
1,391,296
+992,700
| +249% | +$32.4M |
|
|
PDCE
240
DELISTED
PDC Energy, Inc.
PDCE
| $47.3M | 0.12% |
1,146,024
-160,000
| -12% | -$6.46M |
|
|
SJI
241
DELISTED
South Jersey Industries, Inc.
SJI
| $47.1M | 0.12% |
1,598,054
| – | – |
|
242
Kroger
KR
$35.4B
| $47M | 0.11% |
1,462,400
-66,200
| -4% | -$1.92M |
|
243
Trane Technologies
TT
$97.3B
| $46.8M | 0.11% |
738,957
-428,509
| -37% | -$26.2M |
|
244
Yum! Brands
YUM
$43.3B
| $46.8M | 0.11% |
893,848
-32,619
| -4% | -$1.7M |
|
245
Ultragenyx Pharmaceutical
RARE
$2.56B
| $46.8M | 0.11% |
1,066,826
+16,826
| +2% | +$771K |
|
|
MRSH
246
Marsh
MRSH
$91.4B
| $46.7M | 0.11% |
815,304
-16,700
| -2% | -$916K |
|
247
Dollar General
DG
$28.1B
| $46M | 0.11% |
650,599
+191,900
| +42% | +$12.5M |
|
|
XIFR
248
XPLR Infrastructure LP
XIFR
$1.12B
| $45.6M | 0.11% |
1,350,700
+51,700
| +4% | +$1.77M |
|
249
Williams Companies
WMB
$86.7B
| $45.1M | 0.11% |
1,004,290
-17,900
| -2% | -$915K |
|
250
Zoetis
ZTS
$31.9B
| $44.9M | 0.11% |
1,043,451
+86,200
| +9% | +$3.5M |
|
Similar funds
Adage Capital Partners's Q4 2014 Portfolio in Review
As of Q4 2014, Adage Capital Partners held 812 positions worth $40.9B, up 1% from $40.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.26B in Q4 2014, closing 106 positions and reducing 322 holdings. Its most notable exit was Shire pic, an estimated $846M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in AbbVie worth $154M.
- Adage Capital Partners's largest Q4 2014 buy was AbbVie: 2,352,875 shares worth $154M.
- Adage Capital Partners added most to Allergan Inc in Q4 2014, an estimated $166M increase.
- Adage Capital Partners's biggest Q4 2014 reduction was Stanley Black & Decker, cutting an estimated $190M.
- Adage Capital Partners fully exited Shire pic in Q4 2014, selling an estimated $846M.
- Adage Capital Partners's ten largest holdings make up 14% of its $40.9B portfolio in Q4 2014.
- Adage Capital Partners opened 105 new positions and closed 106 in Q4 2014.
- Adage Capital Partners's portfolio value rose 1% quarter-over-quarter to $40.9B.
Based on Adage Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.